Therapies
Wednesday, October 5th, 2016
Neurology, 14 Septemberߠ Objective: To determine patient and hospital characteristics associated with not providing IV tissue plasminogen activator (tPA) to eligible patients with acute ischemic stroke (AIS) in clinical practice. … Conclusions: Overall, about one-quarter of eligible patients with AIS presenting within 2 hours of stroke onset failed to receive tPA treatment. Thrombolysis has improved dramatically over […]
Therapies
Wednesday, October 5th, 2016
Stroke, 23 August 2016 Background and Purpose—Sex-specific disparities in stroke care including thrombolytic therapy and early hospital admission are reported. In a large registry of Florida and Puerto Rico hospitals participating in the Get With The Guidelines—Stroke program, we sought to determine sex-specific differences in ischemic stroke performance metrics and overall thrombolytic treatment. :… Conclusions—Women received comparable stroke […]
Therapies
Wednesday, October 5th, 2016
Stroke, 1 August 2016 Background and Purpose—Understanding physician decision making is increasingly recognized as an important topic of study, especially in stroke care. We sought to characterize the process of acute stroke decision making among neurologists in the United States and Canada from clinical and epistemological perspectives. … Conclusions—Diagnostic certainty and likelihood of treatment with tissue-type plasminogen activator […]
Therapies
Wednesday, October 5th, 2016
Implement Sci, 8 April 2016 Background Thrombolysis using intravenous (IV) tissue plasminogen activator (tPA) is one of few evidence-based acute stroke treatments, yet achieving high rates of IV tPA delivery has been problematic. The 4.5-h treatment window, the complexity of determining eligibility criteria and the availability of expertise and required resources may impact on treatment rates, with […]
Therapies
Wednesday, October 5th, 2016
Stroke, 14 October 2015 Background Primary stroke centers (PSCs) utilize more recombinant tissue plasminogen activator (rt-PA) than non-PSCs. The impact of PSCs on racial disparities in rt-PA use is unknown. … Conclusions Racial disparities in intravenous rt-PA use were not reduced by presentation to PSCs. Black patients were less likely to receive thrombolytic treatment than white patients at […]
Therapies
Friday, August 28th, 2015
J Am Heart Assoc, 12 August 2015 Background Differences in activation of emergency medical services (EMS) may contribute to racial/ethnic and sex disparities in stroke outcomes. The purpose of this study was to determine whether EMS use varied by race/ethnicity and sex among a current, diverse national sample of hospitalized acute stroke patients.… Conclusions EMS […]
Therapies
Friday, August 28th, 2015
Stroke, 2 June 2015 Background and Purpose—Little is known about how regions vary in their use of thrombolysis (intravenous tissue-type plasminogen activator and intra-arterial treatment) for acute stroke. We sought to determine regional variation in thrombolysis treatment and investigate the extent to which regional variation is accounted for by patient demographics, regional factors, and elements […]
Therapies
Friday, August 28th, 2015
Stroke, 13 February 2013 Background and Purpose—We sought to determine hospital and patient characteristics associated with the use of endovascular therapy for acute ischemic stroke and to analyze trends in clinical outcome.… Conclusion—The use of endovascular therapy increased modestly nationally from 2003 to 2012 and decreased in 2013. Clinical outcomes improved notably from 2010 to […]
Therapies
Friday, August 28th, 2015
J Am Heart Assoc, 9 January 2015 Background One third of patients presenting with initially mild strokes have unfavorable outcomes, and the efficacy of intravenous thrombolysis (IVT) in this population has not been proven. This study aimed to evaluate the comparative effectiveness of standard care with IVT versus without IVT in mild stroke patients.… Conclusions […]
Therapies
Friday, August 28th, 2015
Stroke, 6 January 2015 Stroke is a medical emergency and care provided in the first hours is critical in shaping patients’ long-term recovery and prognosis. There is robust evidence demonstrating significant reductions in death and disability with early interventions in acute stroke care, including antiplatelet therapy stroke unit (SU) care and thrombolysis. International clinical guidelines […]
